DNA methylation profiling identifies long-range epigenetic silencing of clustered protocadherins as a key determinant of meningioma progression [RNA-seq]
Hertie-Institute protocadherin silencing cohort
231 meningiomas profiled by DNA methylation array in this discovery cohort, cross-linked to a 10-sample bulk RNA-seq companion, both from the Hertie-Institute for Clinical Brain Research (corresponding authors Daniel J Merk and Ghazaleh Tabatabai). The study title, "DNA methylation profiling identifies long-range epigenetic silencing of clustered protocadherins as a key determinant of meningioma progression," points to protocadherin silencing as the central finding. A related 42-sample longitudinal methylation cohort from the same study (GSE304096) is recorded separately and is not itself flagged as multi-modal matched in this registry, though it shares the same investigators and study family. None of the three records has a linked publication yet, and none of them carry the peer_reviewed tag; treat findings as provisional until a paper is identified.
Overview
- Modality
- Bulk RNA-seq
- Sample count
- 10
- Patient count
- Not reported
- Institution
- Hertie-Institute for Clinical Brain Research
- Corresponding author
- Daniel J Merk, Ghazaleh Tabatabai
- Platform
- Illumina NovaSeq 6000 (GPL24676)
- Access type
- open
- Tissue preservation
- Not reported
- WHO edition
- Not reported
Cohort detail
- Grade breakdown
- Not reported
- Sex distribution
- Not reported
- Age distribution
- Not reported
- Anatomic location
- Not reported
- Brain invasion
- Not reported
- Normal/control tissue
- None
Priority attributes
Publications
No publication linked.
Related datasets
Also related: GSE304093, GSE304096, GSE304097
Sources
- GEOhttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304087